Health systems interested in building a central pharmacy should prioritize personalization and preparation, according to Melanie Massiah-White, vice president and chief pharmacy officer of Fairfax, Va.-based Inova Health System.  “[Spend] time initially scoping services you hope to provide from your…

As semaglutide sees a surge in use, new research raises questions about the medication’s  effects on muscle health. A study published Aug. 5 in Cell Metabolism and led by researchers at Salt Lake City-based University of Utah Health found that…

Texas is seeking more than $1 million from Eli Lilly in a lawsuit accusing the drugmaker of persuading physicians to prescribe its medications, including GLP-1s such as Mounjaro and Zepbound, through kickbacks.  Texas Attorney General Ken Paxton filed the lawsuit…

The American Medical Association and 80 other physician associations are urging Congress to reject a bill that would allow pharmacists to evaluate, diagnose and treat patients in cases that currently require physician oversight.  The Ensuring Community Access to Pharmacist Services…

Eastern Iowa Health Center recently opened a new pharmacy in Cedars Rapids to address a medication access gap after a Hy-Vee closed last summer, Corridor Business Journal reported Aug. 13.  The pharmacy was under development for two years, but the…

The FDA has approved Insmed’s brensocatib, the first treatment for non-cystic fibrosis bronchiectasis, a chronic and progressive lung disease affecting about 500,000 people in the U.S.  The drug was approved for use in adults and children 12 and older and…

The FDA has approved Ketarx, a ketamine-based drug developed by drugmaker PharmaTher, for use in pain management.  The medication is now cleared by the FDA for clinical use in perioperative settings, marking a key development in the medical application of…

Drugmaker Sun Pharma pledged sweeping reforms after years of persistent safety violations at its flagship manufacturing plant in Halol, India, but failed to follow through, according to FDA documents obtained by ProPublica.  The documents also showed the FDA tolerated repeated…

A large-scale cohort study has found that GLP-1s, including Ozempic and Wegovy, may be associated with a modestly increased risk of developing diabetic retinopathy.  The research, published Aug. 11 in JAMA Network Open, analyzed data from over 185,000 individuals with…

A study has found that prescribing semaglutide in everyday clinical settings led to modest but meaningful improvements in cardiovascular risk alongside a rise in non-drug healthcare costs.  The study, published Aug. 8 in JAMA Network Open, analyzed data from more…